Antisense Therapeutics
Clinical trial confirms Antisense Therapeutics drug can inhibit progression of Duchenne muscular dystrophy
Core Lithium
Todd River Resources
Core Lithium completes strategic acquisition of new NT lithium project
Australian Potash
Australian Potash advances feed program with $1.6m placement
Twenty Seven Co
Twenty Seven Co intersects shallow gold up to 20.1 g/t at Creasy 1 in inaugural Rover drilling
Keytone Dairy Corporation
Keytone Dairy (ASX:KTD) merges powder manufacturing facilities
Sigma Healthcare
Why these 10 ASX 200 shares are down more than 10% this month
iSignthis
iSignthis (ASX:ISX) subsidary Probanx contracts further customers
Arafura Resources
Arafura Resources hits up to 43.62 metres at 6.0% TREO and 28% P2O5 at Nolans Bore
De Grey Mining
Exciting new discoveries highlight the scale of De Grey’s Mallina gold project
Noxopharm
Neurotech International
Health: Antisense’s anti-muscular dystrophy drug just took a big step